213 related articles for article (PubMed ID: 19805155)
1. TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.
Kraus ZJ; Nakano H; Bishop GA
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17140-5. PubMed ID: 19805155
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
3. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.
Rastelli J; Hömig-Hölzel C; Seagal J; Müller W; Hermann AC; Rajewsky K; Zimber-Strobl U
Blood; 2008 Feb; 111(3):1448-55. PubMed ID: 18006702
[TBL] [Abstract][Full Text] [Related]
4. TRAF6 is a critical regulator of LMP1 functions in vivo.
Arcipowski KM; Stunz LL; Bishop GA
Int Immunol; 2014 Mar; 26(3):149-58. PubMed ID: 24170780
[TBL] [Abstract][Full Text] [Related]
5. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.
Stunz LL; Busch LK; Munroe ME; Sigmund CD; Tygrett LT; Waldschmidt TJ; Bishop GA
Immunity; 2004 Aug; 21(2):255-66. PubMed ID: 15308105
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.
Peters AL; Stunz LL; Meyerholz DK; Mohan C; Bishop GA
J Immunol; 2010 Oct; 185(7):4053-62. PubMed ID: 20810985
[TBL] [Abstract][Full Text] [Related]
7. TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1.
Arcipowski KM; Bishop GA
J Immunol; 2012 Dec; 189(11):5165-70. PubMed ID: 23109728
[TBL] [Abstract][Full Text] [Related]
8. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
Nakano H; Sakon S; Koseki H; Takemori T; Tada K; Matsumoto M; Munechika E; Sakai T; Shirasawa T; Akiba H; Kobata T; Santee SM; Ware CF; Rennert PD; Taniguchi M; Yagita H; Okumura K
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9803-8. PubMed ID: 10449775
[TBL] [Abstract][Full Text] [Related]
10. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
Uchida J; Yasui T; Takaoka-Shichijo Y; Muraoka M; Kulwichit W; Raab-Traub N; Kikutani H
Science; 1999 Oct; 286(5438):300-3. PubMed ID: 10514374
[TBL] [Abstract][Full Text] [Related]
11. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).
Brown KD; Hostager BS; Bishop GA
J Exp Med; 2001 Apr; 193(8):943-54. PubMed ID: 11304555
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.
Munroe ME; Anderson JR; Gross TF; Stunz LL; Bishop GA; James JA
Front Immunol; 2020; 11():606936. PubMed ID: 33613527
[TBL] [Abstract][Full Text] [Related]
13. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
Wu S; Xie P; Welsh K; Li C; Ni CZ; Zhu X; Reed JC; Satterthwait AC; Bishop GA; Ely KR
J Biol Chem; 2005 Sep; 280(39):33620-6. PubMed ID: 16009714
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
15. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
[TBL] [Abstract][Full Text] [Related]
16. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
[TBL] [Abstract][Full Text] [Related]
17. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
18. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
19. Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1.
Arcipowski KM; Bishop GA
PLoS One; 2012; 7(7):e42478. PubMed ID: 22860133
[TBL] [Abstract][Full Text] [Related]
20. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
Ishida TK; Tojo T; Aoki T; Kobayashi N; Ohishi T; Watanabe T; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9437-42. PubMed ID: 8790348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
